[go: up one dir, main page]

AU2001247274A1 - Melanoma differentiation associated gene - 5 and promoter and uses thereof - Google Patents

Melanoma differentiation associated gene - 5 and promoter and uses thereof

Info

Publication number
AU2001247274A1
AU2001247274A1 AU2001247274A AU4727401A AU2001247274A1 AU 2001247274 A1 AU2001247274 A1 AU 2001247274A1 AU 2001247274 A AU2001247274 A AU 2001247274A AU 4727401 A AU4727401 A AU 4727401A AU 2001247274 A1 AU2001247274 A1 AU 2001247274A1
Authority
AU
Australia
Prior art keywords
promoter
associated gene
melanoma differentiation
differentiation associated
melanoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001247274A
Inventor
Paul B. Fisher
Rahul V. Gopalkrishnan
Dong-Chul Kang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Original Assignee
Columbia University in the City of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia University in the City of New York filed Critical Columbia University in the City of New York
Publication of AU2001247274A1 publication Critical patent/AU2001247274A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU2001247274A 2000-02-29 2001-02-28 Melanoma differentiation associated gene - 5 and promoter and uses thereof Abandoned AU2001247274A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/515,363 US7229822B1 (en) 2000-02-29 2000-02-29 Melanoma differentation associated gene-5 and vectors and cells containing same
US09515363 2000-02-29
PCT/US2001/006960 WO2001064707A1 (en) 2000-02-29 2001-02-28 Melanoma differentiation associated gene - 5 and promoter and uses thereof

Publications (1)

Publication Number Publication Date
AU2001247274A1 true AU2001247274A1 (en) 2001-09-12

Family

ID=24051036

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001247274A Abandoned AU2001247274A1 (en) 2000-02-29 2001-02-28 Melanoma differentiation associated gene - 5 and promoter and uses thereof

Country Status (6)

Country Link
US (5) US7229822B1 (en)
EP (1) EP1259530A4 (en)
JP (1) JP2003531581A (en)
AU (1) AU2001247274A1 (en)
CA (1) CA2401741A1 (en)
WO (1) WO2001064707A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2808801B1 (en) * 2000-05-11 2004-10-08 Istac POLYPEPTIDE RH116 AND ITS FRAGMENTS AND POLYNUCLEOTIDES ENCODING SAID POLYPEPTIDES AND THERAPEUTIC APPLICATIONS
JP2005073621A (en) * 2003-09-01 2005-03-24 Japan Science & Technology Agency Brain tumor marker and diagnostic method for brain tumor
WO2008048976A2 (en) * 2006-10-18 2008-04-24 The Government Of The United States Of America As Represented By The Secretary Of The Deparment Of Health And Human Services, Centers For Disease Control And Prevention Enhancing disease resistance against rna viral infections with intracytoplasmic pathogen sensors
WO2009085277A2 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Treatment of abnormal or excessive scars
WO2010024089A1 (en) * 2008-09-01 2010-03-04 学校法人慶應義塾 Diagnosis method and diagnosis kit for dermatomyositis
MX341877B (en) 2009-06-26 2016-09-06 Romark Laboratories L C * COMPOUNDS AND METHODS TO TREAT INFLUENZA.
ES2368963B1 (en) * 2009-07-04 2012-10-10 Fundación Centro Nacional De Investigaciones Oncológicas Carlos Iii PROCEDURE FOR IDENTIFICATION OF THERAPEUTIC AGENTS AGAINST MELANOMA AND USE OF IDENTIFIED AGENT.
US10745439B2 (en) * 2017-03-20 2020-08-18 Regents Of The University Of Minnesota Kinase substrates and methods of use thereof
WO2022045126A1 (en) * 2020-08-25 2022-03-03 学校法人 久留米大学 Viral infection determination method

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952097A (en) * 1974-09-27 1976-04-20 The United States Of America As Represented By The Department Of Health, Education And Welfare Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid
ZA892518B (en) 1988-04-08 1989-12-27 Intracel Corp Method for the in-vivo production and testing of proteins by recombinant gene expression in selected host-cells
WO1990011092A1 (en) 1989-03-21 1990-10-04 Vical, Inc. Expression of exogenous polynucleotide sequences in a vertebrate
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
CA2135312C (en) 1992-05-13 2006-09-26 Charles Myers Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy
US5399466A (en) * 1993-01-15 1995-03-21 Eastman Kodak Company [Method of processing] photographic elements having fogged grains and development inhibitors for interimage
US5496731A (en) 1993-03-25 1996-03-05 Xu; Hong-Ji Broad-spectrum tumor suppressor genes, gene products and methods for tumor suppressor gene therapy
US5643761A (en) 1993-10-27 1997-07-01 The Trustees Of Columbia University In The City Of New York Method for generating a subtracted cDNA library and uses of the generated library
WO1995011986A1 (en) 1993-10-27 1995-05-04 The Trustees Of Columbia University In The City Of New York METHOD FOR GENERATING A SUBTRACTED cDNA LIBRARY AND USES OF THE GENERATED LIBRARY
US6051376A (en) 1994-09-30 2000-04-18 The Trustees Of Columbia University In The City Of New York Uses of mda-6
US6025127A (en) 1994-01-14 2000-02-15 The Johns Hopkins University School Of Medicine Nucleic acid mutation detection in histologic tissue
US6207145B1 (en) * 1997-05-09 2001-03-27 Pharma Pacific Pty Ltd. Therapeutic applications of high dose interferon
US20020048763A1 (en) 2000-02-04 2002-04-25 Penn Sharron Gaynor Human genome-derived single exon nucleic acid probes useful for gene expression analysis
FR2808801B1 (en) * 2000-05-11 2004-10-08 Istac POLYPEPTIDE RH116 AND ITS FRAGMENTS AND POLYNUCLEOTIDES ENCODING SAID POLYPEPTIDES AND THERAPEUTIC APPLICATIONS

Also Published As

Publication number Publication date
EP1259530A1 (en) 2002-11-27
US20070259372A1 (en) 2007-11-08
EP1259530A4 (en) 2005-01-12
CA2401741A1 (en) 2001-09-07
WO2001064707A1 (en) 2001-09-07
JP2003531581A (en) 2003-10-28
US7229822B1 (en) 2007-06-12
US20030092043A1 (en) 2003-05-15
US20050186211A1 (en) 2005-08-25
US7220575B2 (en) 2007-05-22
US20030022855A1 (en) 2003-01-30

Similar Documents

Publication Publication Date Title
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU6820000A (en) Novel proteases and variants thereof
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001273569A1 (en) Perfluoropolyethers and processes therefor and therewith
AU2001261377A1 (en) Novel anti-infectives
AU7563800A (en) Marsh-mallow and the marsh-mallow production technique
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU6474400A (en) Compressor
AU2002211717A1 (en) Stresscopins and their uses
AU7073800A (en) Novel plexins and uses thereof
AU2002212839A1 (en) Surveillance arrangement and controller
AU2001259511A1 (en) Novel anti-infectives
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU2841801A (en) Triazolotriazinones and the use thereof
AU2001247274A1 (en) Melanoma differentiation associated gene - 5 and promoter and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2002228921A1 (en) Arcelin-5 promoter and uses thereof
AU2001262963A1 (en) Laminin 15 and uses thereof
AU2001241942A1 (en) Melanoma differentiation associated gene - 7 promoter and uses thereof
AU2285701A (en) Proteases